Omkar Speciality Chemicals Limited - Q1FY16 Total Income Rises 69.08% & PAT up by 64.41%

Consolidated Results

Total Income up by 69.08 % at Rs. 90.48 crore

Q1FY16 PAT up by 64.41 % at Rs. 8.17 crore

Results Highlight:

For the Quarter ended June 30, 2015 (Q1FY16):

• Net Profit of Rs. 8.17 crore; y-o-y growth of 64.41%

• EBITDA of Rs. 17.26 crore; recording a growth of 98.02%

• Total Income of Rs. 90.48 crore; as compared to Rs. 53.51 in Q1FY15

• EPS for Q1FY16 stood at Rs. 3.97, as compared to Rs. 2.41 for Q1FY15                                                                                                                             

Omkar Speciality Chemicals Ltd (OSCL), a leading company in the field of Speciality Chemicals and Active Pharmaceutical Ingredients (APIs), today declared its financial results for the first quarter ended June 30, 2015.

The company reported a healthy increase of 64.41% in its Net Profit to Rs. 8.17 crore for Q1FY16, as compared to Rs. 4.97 crore in the corresponding quarter of last fiscal.

Total Income for the quarter ended June 30, 2015 stood at Rs. 90.48 crore, as compared to Rs. 53.51 crore in the same period last year.

OSCL’s Earnings before Interest, Tax, Depreciation and Amortization (EBITDA) in Q1FY16 stood at Rs. 17.26 crore, up 98.02%. The company’s EBITDA margin improved from 16.29% in Q1FY15 to 19.08% in Q1FY16.

Commenting on the financial performance of the company Mr. Omkar Herlekar, the Whole Time Director, Omkar Speciality Chemicals Ltd, said, “It is great to start off this fiscal year with a robust increase in our top-line with the commencement of operations of the additional capacity at Chiplun. We believe traction in sales to continue over the coming quarters with a steady improvement in capacity utilization. The margins have increased because of higher composition of speciality chemicals and APIs in the total sales.”

Earnings per share (EPS) for the quarter ended Q1FY16 stood at Rs. 3.97, up 64.73% as compared with Rs. 2.41 for the quarter ended June 30, 2014.

About Omkar Speciality Chemicals Limited (www.omkarchemicals.com; BSE: 533317; NSE: OMKARCHEM)

A leading speciality chemicals company, OSCL’s core business is manufacturing of niche lifesaving intermediates, Active Pharmaceuticals Ingredients (APIs) and Veterinary Growth enhancers. Headquartered at Thane, OSCL has nine units in the state of Maharashtra, India with over 1,100 workforce. The company is fully backward integrated and has an installed capacity of 4,920 MTPA. The Company’s product segments include Iodine Compounds, Selenium Compounds, Intermediates, Resolving Agents, Veterinary Growth Enhancers and APIs which comprises of more than 200 products. The Inorganic Intermediates include Selenium derivatives and Iodine derivatives. These products find applications in various industries like Pharmaceutical Industry, Chemical Industry, Glass Industry, Cosmetics, Ceramic Pigments and Cattle & Poultry Feeds. The company’s association with leading organizations in India and abroad has enabled it to broaden its business, to expand the existing product range and to develop new molecules as per the specific requirements of customers. The company is certified with ISO 9001:2008 and FAMI-QS & GMP